April 29, 2012
Two new obesity drugs, Qnexa and Lorcaserin, are awaiting FDA approval. These drugs could help obese patients lose a substantial amount of weight. Chris Chan reports.
Topics: Hospitality Recreation, Health Medical Pharma, Social Issues, Health, Obesity, Bariatrics, Nutrition, Medicine, Lorcaserin, Anti-obesity medication, Food and Drug Administration, Metabolic disorders, Body shape